Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2014
06/18/2014CN103874507A Parenteral norovirus vaccine formulations
06/18/2014CN103874506A Blood stage malaria vaccine
06/18/2014CN103874505A Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
06/18/2014CN103874504A Vaccine
06/18/2014CN103874503A Anti-P-selectin antibodies and methods of their use and identification
06/18/2014CN103874494A Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab
06/18/2014CN103865938A Establishment method of clostridium difficile exotoxin A carboxyl-terminal sequence codon optimization gene segment and expression vector and application of expression protein thereof
06/18/2014CN103865923A Preparation and application of influenza virus-carried HAdV (human adenovirus) chimeric vaccine
06/18/2014CN103865892A Functional influenza virus like particles (VLPs)
06/18/2014CN103865890A Recombinant virus for preventing viral myocarditis as well as vaccine and applications tof recombinant virus
06/18/2014CN103865889A Rabies virus CTN chick-embryo cell adaptive strain
06/18/2014CN103865888A Adapting method of rabies virus (RV) CTN-1 strain to primary chicken embryo fibroblast
06/18/2014CN103865884A Duck viral hepatitis bivalent yolk antibody, preparation method and application thereof
06/18/2014CN103865878A Monoclonal antibody for antagonistic inhibition of combination of vascular endothelial cell growth factor and receptor thereof, hybridoma cell line secreting monoclonal antibody, and use of monoclonal antibody
06/18/2014CN103865859A Staphylococcus sciuri, vaccine and preparation method thereof
06/18/2014CN103865834A Haemophilus parasuis with double-gene deletion and construction method thereof
06/18/2014CN103864939A mGM-CSF/beta hCG fusion protein, and preparation method and application thereof
06/18/2014CN103864936A HPV18 type L2NE7E6 fusion protein gene, and expression vector, preparation method, strain and use thereof
06/18/2014CN103864935A Targeted EGFR/KDR (Epidermal Growth Factor Receptor/Kinase Insert Domain Receptor) specific diabody
06/18/2014CN103864934A Anti-il-22ra antibodies and binding partners and methods of using in inflammation
06/18/2014CN103864932A Monoclonal antibody for antagonistically inhibiting combination of vascular endothelial growth factor with its receptor, and coding sequence and use thereof
06/18/2014CN103864926A Method for preparing rabies human immune globulin by inactivation of double viruses
06/18/2014CN103864925A Heavy chain and light chain variable region of high-neutralizing activity anti-Japanese encephalitis virus (JEV) monoclonal antibody
06/18/2014CN103864924A Middle east and respiratory syndrome coronavirus antibody and preparation method thereof
06/18/2014CN103864923A Glycosylated antibodies
06/18/2014CN103864921A Folic acid-adriamycin immunological preparation for treating cancer through dual targets and preparation method thereof
06/18/2014CN103864907A Protein and kit for tuberculosis diagnosis
06/18/2014CN103864905A CTL (Cytotoxic T Lymphocyte) epitope peptide of foot-and-mouth disease virus type O and screening method of CTL epitope peptide
06/18/2014CN103864904A Antigen fragment and truncation based on ebola virus envelope protein as well as application
06/18/2014CN103864903A Hepatitis B virus surface antigen recombinant chimeric protein, preparation method and application thereof
06/18/2014CN103861107A Pharmaceutical composition and uses thereof
06/18/2014CN103861106A Antagonists of IL-6 to raise albumin and/or lower CRP
06/18/2014CN103861102A Anti-CTLA-4 antibody compositions
06/18/2014CN103861101A Novel chimeric flagellin adjuvant of helicobacter pylori multi-epitope vaccine
06/18/2014CN103861100A Vaccine compositions comprising saponin adjuvant
06/18/2014CN103861099A VACCINE ADJUVANT, VACCINE COMPOSITION AND usage of Antrodia camphorate sporocarp
06/18/2014CN103861098A Bivalent vaccine for preventing porcine epidemic diarrhea and Escherichia coli
06/18/2014CN103861097A Method for preparing porcine epizootic diarrhea inactivated vaccines and product thereof
06/18/2014CN103861096A Preparation method of live vaccine for treating porcine reproductive and respiratory syndrome with high pathogenicity and live vaccine product
06/18/2014CN103861095A Vaccine composition containing swine mycoplasmal pneumonia antigen and swine streptococcosis antigen, and preparation method and application thereof
06/18/2014CN103861094A Clostridium perfringen alpha toxin genetic engineering vaccine and application thereof
06/18/2014CN103861093A Sheep hydatid cyst subunit vaccine, and preparation method and application thereof
06/18/2014CN103316334B Infectious bursal disease live vaccine and production method thereof
06/18/2014CN103272233B Application of MLL (mixed lineage leukemia) 1 antibody and expression inhibiter in preparing medicine for treating AML (acute myeloid leukemia)
06/18/2014CN103012587B Preparation, identification and application of monoclonal antibody of specific human lung resisting specific X protein
06/18/2014CN103007275B Combined trivalent live vaccine for Newcastle disease and infectious chicken bronchitis
06/18/2014CN102988976B Hepatitis B virus core antigen-DNA (deoxyribonucleic acid) compound vaccine and preparation method thereof
06/18/2014CN102988970B Foot-and-mouth disease purification vaccine, preparation method and applications thereof
06/18/2014CN102899295B Duck hemorrhagic ovaritis virus
06/18/2014CN102732533B Vaccine produced by using Cryptocaryon irritans immbolization antigen to complement deoxyribonucleic acid, and production method and application thereof
06/18/2014CN102659923B Epitope minimal motif peptides of human zona pellucida protein-4 and extended short peptides and application thereof
06/18/2014CN102596996B Antibody having activity of inhibiting infection with hepatitis c virus (HCV) and use of same
06/18/2014CN102596238B Apparatus and method for cryogranulating a pharmaceutical composition
06/18/2014CN102392049B Preparation method for hepatitis E virus antigen and product thereof
06/18/2014CN102302776B Injectable vaccines against multiple meningococcal serogroups
06/18/2014CN102271711B Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
06/18/2014CN101970488B Humanized antibody molecules specific for il-31
06/18/2014CN101947306B Treatment of T-cell mediated diseases
06/18/2014CN101890160B Multivalent recombinant human papilloma virus vaccine and application thereof
06/18/2014CN101804202B Methods of producing influenza vaccine compositions
06/18/2014CN101675075B Recombinant anti-epidermal growth factor receptor antibody compositions
06/18/2014CN101479296B TRAIL receptor-binding agents and uses of the same
06/18/2014CN101171034B Humanized L243 antibodies
06/18/2014CN101155830B Antibodies that bind to epha2 and methods of use thereof
06/17/2014US8754199 Tango 240 nucleic acids and uses thereof
06/17/2014US8754196 Chromatography matrices including novel Staphylococcus aureus protein A based ligands
06/17/2014US8754050 Macrocyclic compounds useful as inhibitors of histone deacetylases
06/17/2014US8754046 MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
06/17/2014US8754031 Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
06/17/2014US8753843 Antibodies to IL-17A
06/17/2014US8753839 Compositions and methods for crystallizing antibodies
06/17/2014US8753673 Liposome composition for delivery of a therapeutic agent to eyes
06/17/2014US8753651 Capsular polysaccharide solubilisation and combination vaccines
06/17/2014US8753650 Staphylococcus aureus proteins and nucleic acids
06/17/2014US8753649 Polysaccharide-protein conjugate vaccines
06/17/2014US8753648 Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
06/17/2014US8753647 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
06/17/2014US8753646 IPV-DPT vaccine
06/17/2014US8753645 Conjugation process of bacterial polysaccharides to carrier proteins
06/17/2014US8753644 Grass peptides for vaccine
06/17/2014US8753643 Spray dried compositions and methods of use
06/17/2014US8753641 Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
06/17/2014US8753638 Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities
06/17/2014US8753637 Binding partners for the thyrotropin receptor and uses thereof
06/17/2014US8753636 Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof
06/17/2014US8753635 Monoclonal antibodies to anthrax protective antigen
06/17/2014US8753634 Anti-IL-6 receptor antibodies and methods of use
06/17/2014US8753633 Human antibodies that bind human TNFα
06/17/2014US8753632 Antibodies to modified human IGF-1/E peptides
06/17/2014US8753631 Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders
06/17/2014US8753630 Using EGFRvIII to identify and target cancer stem cells
06/17/2014US8753629 Optimized Fc variants
06/17/2014US8753628 Optimized Fc variants
06/17/2014US8753627 Anti-activin a antibodies and uses thereof
06/17/2014US8753625 Use of complement inhibitors to treat ocular diseases
06/17/2014US8753623 Influenza vaccine
06/17/2014US8753622 Seneca valley virus based compositions and methods for treating disease
06/17/2014CA2709354C Anti-amyloid antibodies and uses thereof
06/17/2014CA2664795C Therapeutic compositions to improve the effect of the therapy with anti-epidermal growth factor receptor antibodies
06/17/2014CA2635599C Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 1823